Internal Medicine, Critical Care Medicine · Hannibal, MO
NPI
1306880141
Since 2006
Specialty
Internal Medicine, Critical Care Medicine
Code 207RC0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
100 Medical Dr
Hannibal, MO, 63401
Phone (573) 231-3766
Groups this clinician bills Medicare through
Medicare paid, 2024
$370K
7,585 services
Medicare patients, 2024
1,307
Average age 73
Drug cost, 2024
$7.8M
6,289 prescriptions
Company payments, 2025
$141K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Humam W Farah was code 99232 (hospital e&m - subsequent), 1,943 times for 315 patients. In total Humam W Farah billed 7,585 services in 23 codes, and Medicare paid $370K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,943 | 315 | $57.59 | $112K |
| 99213 Office E&M - Established | Office | 1,358 | 805 | $44.97 | $61K |
| 99214 Office E&M - Established | Office | 602 | 372 | $67.03 | $40K |
| 94729 Pulmonary Function Testing | Office | 552 | 543 | $6.29 | $3,470 |
| 94060 Pulmonary Function Testing | Office | 552 | 543 | $7.23 | $3,991 |
| 94726 Pulmonary Function Testing | Office | 552 | 543 | $8.46 | $4,667 |
| 94618 Pulmonary Function Testing | Office | 487 | 468 | $15.34 | $7,471 |
| 99222 Hospital E&M - Initial | Facility | 376 | 270 | $93.44 | $35K |
| 99291 Critical Care E&M | Facility | 201 | 103 | $153.37 | $31K |
| 99233 Hospital E&M - Subsequent | Facility | 194 | 90 | $86.93 | $17K |
| 99204 Office E&M - New | Office | 171 | 171 | $89.98 | $15K |
| 99213 Office E&M - Established | Facility | 97 | 97 | $49.02 | $4,755 |
| 99214 Office E&M - Established | Facility | 64 | 58 | $72.27 | $4,625 |
| 94618 Pulmonary Function Testing | Facility | 59 | 59 | $16.41 | $968 |
| 94726 Pulmonary Function Testing | Facility | 54 | 54 | $8.84 | $477 |
By year: 2022 $1.6M for 292,389 services; 2023 $655K for 83,473 services; 2024 $370K for 7,585 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 164 | 137 | $8.40 | $1,378 |
| 85025 Blood Count | 43 | 42 | $7.61 | $327 |
| 82104 Clinical Chemistry | 42 | 42 | $14.17 | $595 |
| 80076 Clinical Chemistry | 40 | 26 | $8.01 | $320 |
| 82103 Clinical Chemistry | 40 | 40 | $13.17 | $527 |
| 82785 Immunoassay | 20 | 20 | $16.13 | $323 |
Medicare prescription drug claims, 2024
In 2024, the drug Humam W Farah prescribed most often to Medicare patients was Breztri Aerosphere (Budesonide/Glycopyr/Formoterol), with 1,220 prescriptions and refills. In total Humam W Farah wrote 6,289 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 1,220 | 1,475 | 277 | $924K |
| Azithromycin Generic | 845 | 1,057 | 324 | $4,909 |
| Prednisone Generic | 648 | 652 | 314 | $1,333 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 450 | 489 | 115 | $13K |
| Ventolin Hfa Albuterol Sulfate | 238 | 247 | 58 | $14K |
| Spiriva Respimat Tiotropium Bromide | 233 | 266 | 50 | $141K |
| Fluticasone Propionate Generic | 195 | 334 | 76 | $2,927 |
| Modafinil Generic | 151 | 173 | 25 | $32K |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 131 | 137 | 23 | $68K |
| Symbicort Budesonide/Formoterol Fumarate | 118 | 155 | 31 | $36K |
| Wakix Pitolisant Hcl | 109 | 115 | 13 | $1.6M |
| Breo Ellipta Fluticasone/Vilanterol | 92 | 106 | 18 | $42K |
| Sildenafil Citrate Generic | 90 | 104 | 17 | $11K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 89 | 105 | 20 | $64K |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 82 | 82 | 64 | $586 |
Brand drugs: 3,339 claims; generic drugs: 2,950 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Humam W Farah $141K ($141K in general payments such as food, travel and fees) from 32 companies. The largest payer was Verona Pharma, Inc. with $77K.
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. VRNA | 77 | $77K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 40 | $26K |
| AstraZeneca Pharmaceuticals LP AZN | 41 | $25K |
| Viatris Specialty LLC | 24 | $11K |
| Olympus Corporation of the Americas | 4 | $423 |
| Harmony Biosciences LLC HRMY | 18 | $417 |
| Actelion Pharmaceuticals US, Inc. JNJ | 7 | $191 |
| Insmed, Inc. INSM | 6 | $110 |
| United Therapeutics Corporation UTHR | 1 | $110 |
| ANI Pharmaceuticals, Inc. ANIP | 3 | $75.37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.